Compounds of formulas 1 through 17 provided in the specification specifically or selectively inhibit either the cytochrome P450RAI-1 enzyme or the cytochrome P450RAI-2 enzyme.

 
Web www.patentalert.com

> Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
~ 00352